Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study

• Authors: OSTERBORG A.; JEWELL R.C.; PADMANABHAN-IYER S.; KIPPS T.J.; MAYER Jiří; STILGENBAUER S.; WILLIAMS C.D.; HELLMANN A.; FURMAN R.R.; ROBAK T.; HILLMAN P.; TRNENY M.; DYER M.J.S.; PIOTROWSKA M.; KOZAK T.; GUPTA I.V.; PHILLIPS J.L.; GOLDSTEIN N.; STRUEMPER H.; LOSIC N.; LISBY S.; WIERDA W.G.
• Year of publication: 2015
• Type: Article in Periodical
• Magazine / Source: Haematologica
• MU Faculty or unit: Faculty of Medicine
• Doi: http://dx.doi.org/10.3324/haematol.2014.121459
• Field: Oncology and hematology
• Keywords: ofatumumab; fludarabine-refractory; pivotal study
• Description: Study of Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study.